XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.19.1

Earnings Per Share | 3 Months Ended
--- | ---
Mar. 30, 2019
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share The shares used in the computation of the company’s basic and diluted earnings per common share are as follows:
| Three Months Ended |
| March 30, 2019 |  | March 31, 2018 |
Weighted-average common shares outstanding | 55,514,520 |  |  | 56,651,508 |  |
Effect of dilutive securities | 790,637 |  |  | 1,113,721 |  |
Weighted-average common shares outstanding, assuming dilution | 56,305,157 |  |  | 57,765,229 |  |
The dilutive effect of the potential exercise of outstanding options and stock-settled SARs to purchase common shares is calculated using the treasury stock method. As of March 30, 2019, there were 1,233,467 awards outstanding that were anti-dilutive; as of March 31, 2018, there were 715,083 awards outstanding that were anti-dilutive. Performance-based equity awards are included in the diluted earnings per share calculation based on the attainment of the applicable performance metrics to date.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration